Phase III study of selpercatinib vs chemotherapy +/â pembrolizumab in untreated RET positive non-small-cell lung cancer
Solomon, Benjamin J, Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jürgen, Elamin, Yasir, Davis, Hannah M, Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K, F LoongЖурнал:
Future Oncology
DOI:
10.2217/fon-2020-0935
Date:
November, 2020
Файл:
PDF, 1.93 MB
2020
File converter
Більше результатів пошуку
More benefits 
